| 2025 | ||
|---|---|---|
| Gross margin | -194,0 k € | |
| EBITDA | -194,0 k € | |
| Operating profit | -782,8 k € | |
| Profit/loss | -790,2 k € | |
| Equity | -506,8 k € | |
| Total assets | 56,7 k € | |
| Cash | 35,4 k € | |
| Debts | 556,7 k € | |
Private limited company · Leuven · incorporated on 01/03/2024
Private limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Benno Therapeutics is a Private limited company incorporated in 2024. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Leuven.